Article Text


Effectiveness of extracorporeal shock wave therapy for tennis elbow (lateral epicondylitis)
  1. D Stasinopoulos1,
  2. M I Johnson2
  1. 1Centre of Rheumatology and Rehabilitation, Athens, Greece and Department of Health and Environment, Leeds Metropolitan University, Leeds, UK
  2. 2Leeds Metropolitan University
  1. Correspondence to:
 D Stasinopoulos
 Rheumatology and Rehabilitation Centre, Orfanidou 16, Patissia, Athens 11141, Greece;


Randomised controlled trials were reviewed to evaluate the evidence of the effectiveness of extracorporeal shock wave therapy in the management of tennis elbow. Seven relevant trials were found, which had satisfactory methodology but conflicting results. Further research with well designed randomised control trials is needed to establish the absolute and relative effectiveness of this intervention for tennis elbow.

Statistics from

Lateral epicondylitis or tennis elbow is one of the most common lesions of the arm. This injury is a major challenge, as it is difficult to treat, prone to recurrence, and may last for several weeks or months, with the average duration of a typical episode reported to be between six months and two years.1

Tennis elbow is defined as pain on the facet of the lateral epicondyle, which is reproduced by digital palpation on the above site, resisted wrist extension, resisted middle finger extension, and gripping.2–4 The dominant arm is commonly affected, with a prevalence of 1–3% in the general population, but this increases to 19% in 30–60 year olds and appears to be more long standing and severe in women.3,5–8 It is generally a work related or sport related disorder of the common extensor origin of the arm, usually caused by excessive, quick, monotonous, repetitive movements of the wrist, especially in eccentric contractions and gripping activities causing macroscopic and microscopic tears in the extensor carpi radialis brevis tendon, the most commonly affected structure.3,6,9–12 It is a degenerative or failed healing tendon response characterised by the increased presence of fibroblasts, increased amounts of proteoglycans and glycosaminoglycans, vascular hyperplasia, and disorganised collagen in the origin of the extensor carpi radialis brevis tendon.13–19 The diagnosis is simple and confirmed by tests that can be used in daily clinical practice such as palpation on the facet of the lateral epicondyle, the Tomsen test, handgrip dynamometer testing, Mill’s test, chair test, and the coffee cup test.20–26

Although the diagnosis of this condition is simple and easy, its management is difficult. Conservative treatment is the primary choice, but a plethora of interventions, medical and physiotherapeutic with different theoretical mechanisms of action, have been reported, all with the single aim of reducing pain and improving functional status. However, such a variety of treatment options suggests that the optimal management strategy is not known, and more research to discover the most effective treatment is needed.

Extracorporeal shock wave therapy (ESWT) is a recently introduced modality for the management of tennis elbow. Its effectiveness has been evaluated in a review,27 but conclusions, positive or negative, cannot be drawn from this review because of the small number of studies included. As it is the only systematic review of the effectiveness of ESWT in the management of tennis elbow based on literature published until 2002, and several new randomised controlled trials (RCTs) have been published since then, an updated systematic review seemed to be indicated. Therefore the aim of this article was to determine the effectiveness of ESWT in the management of tennis elbow and to provide recommendations based on this evidence.


Search strategy

Computerised searches were performed using Medline (from 1966 to August 2004), Embase (from 1988 to August 2004), Cinahl (from 1982 to August 2004), Index to Chiropractic Literature (from 1992 to August 2004), Chirolars (from 1994 to August 2004) and SportsDiscus (from 1990 to August 2004) databases. Only English language publications were considered. The following search terms “tennis elbow”, “lateral epicondylitis”, “lateral epicondylalgia”, “rehabilitation”, “extracorporeal shock wave therapy”, “management”, “clinical trials”, and “randomised control trials” were used individually or in various combinations. Other references were identified from existing reviews and other papers cited in the publications searched. Further citations were sought from the reference sections of papers retrieved, from contacting experts in the field, and from the Cochrane Collaboration (last search July 2004), an international network of experts who search journals for relevant citations. Unpublished reports and abstracts were not considered. Keywords and search strategy were selected by the researcher only, without the help of an expert librarian with experience in searching databases to computerised health literature.

Selection of studies

To be included within the review, studies had to fulfil the following conditions: it had to be a RCT, with or without follow up, which included subjects aged 18 and above treated for tennis elbow. The treatment had to be any type of ESWT evaluated against at least one of the following: (a) placebo; (b) no treatment; (c) another treatment, conservative (physical therapy intervention or medical) or operative. RCTs in which the ESWT was given as part of the treatment—for example, non-steroidal anti-inflammatory drugs and ESWT or ultrasound and exercise programme and ESWT—were excluded, because we would not know how each modality contributed to the results. However, the effectiveness of these management strategies has not been assessed in the literature. Data were sought for one of the following four primary outcome measures: pain (scales or descriptive words), function (scales, tests, or descriptive words), grip strength (pain-free or maximum), and a global measure (overall improvement, proportions of patients recovered, subjective improvement of symptoms).

The titles and abstracts of all studies were assessed for the above eligibility criteria. If it was absolutely clear from information provided in the title and/or abstract that the study was not relevant, it was excluded. If it was unclear from the available abstract and/or the title, the full text article was retrieved. There was no blinding to study author, place of publication, or results. The researcher assessed the content of all full text articles, making the selection criteria.

Methodological quality

The quality of the selected papers was examined using the system proposed by Chalmers et al,28 with some minor modifications, which evaluates the design and conduct of the research by scoring the quality. According to Labelle et al,29 it is possible to interpret the results appropriately using this system, especially when there are conflicting results between two studies, or studies with small sample size and inconclusive results.

The Chalmers’ technique consists of two evaluation forms with 29 individually scored items, allowing a maximum score of 100. The first form examines the study design, giving particular importance to blinding of patients and doctors, and the presence and method of randomisation of the patients and doctors when applicable (table 1). The second form evaluates the quality of the data analysis, the statistical analysis, and the presentation of results (table 2).

Table 1

 Evaluation form A, adapted from Chalmers et al,28 showing the 15 items scored to evaluate the study design of a clinical trial

Table 2

 Evaluation form B adapted from Chalmers et al28 showing the 14 items scored to evaluate the data analysis of a clinical trial

This system has been applied to several therapeutic trials, and an arbitrary score of 70% is considered to be the minimum required for a high quality design for controlled therapeutic trials. If the score is below 40% (0–39), the design of the study is low quality, and, if it is 40–69%, it is satisfactory.29

Data abstraction

Raw data on means for all outcomes, as well as the authors’ report of the study results, were extracted from the full manuscripts by the reviewer. Data on adverse events were abstracted from the studies.

Basic data were extracted including characteristics of participants (age, sex, previous treatments, and duration of disorder), outcomes (type of outcome measure and instrument), and interventions (type, dose or intensity, frequency, and duration).


Trial flow

From the initial examination of citations, yielded from the literature search, 12 studies were included. After review of the completed texts, five studies were excluded,30–34 leaving seven eligible RCTs, to be included in the review.35–41 No additional eligible RCTs were found by screening the references.

Description of studies

Four studies35,37,38,41 explicitly excluded patients with concomitant neck, thorax, or shoulder complaints, and the rest36,39,40 excluded only patients with concomitant neck or thorax complaints.

All studies except Rompe et al40 and Melegati et al41 performed a short term outcome assessment (four to six weeks after the end of treatment). Five studies35,37,39–41 included a long term follow up (six months or more after the end of treatment).

In all studies, the study population consisted of subjects of both sexes over a wide range of ages suffering from tennis elbow.

Pain and function were the primary outcome measures for all studies. Pain was measured in all studies either by visual analogue scales, ordinal scales from 3 to 9 points, or descriptive words. Function had also been measured in all studies except those of Speed et al36 and Crowther et al38 either by visual analogue scales, questionnaire, or tests such as the lifting test. Other outcome measures were grip strength and global improvement or patient satisfaction. Grip strength was reported in all studies, except those of Speed et al,36 Crowther et al,38 and Melegati et al.41 Grip strength was measured as maximum grip strength40 in one study, and three studies did not specify the way that grip strength was measured.35,37,39 A great variety of outcome measures were used to describe global improvement or patient satisfaction. Crowther et al38 and Speed et al36 did not report global improvement or patient satisfaction.

Almost all studies apart from that of Melegati et al41 had adequate blinded outcome assessors. Three studies gave enough details in relation to the blinding of patients and therapists.37,39,41

Four studies had used a proper method of randomisation,37,38,40,41 whereas the rest did not clearly describe the randomisation process.

All studies reported dropouts and the reasons. Side effects were also reported in all studies.

The sample size of the studies ranged between 20–2141 and 136–13737 patients per intervention group. Only two studies stated the power calculations for the sample size.37,40


Table 3 gives our evaluation for the seven clinical trials, expressing the results as percentages of the maximum possible score and allowing for items which were not applicable to every study and were therefore excluded from the calculations. The average score for the seven trials was 59.2%, with a minimum of 45% for the weakest study design41 and a maximum of 75% for the strongest one.37 All studies had a satisfactory quality design.

Table 3

 Results for seven papers on treatment by extracorporeal shock wave therapy (ESWT)

Five out of seven studies compared ESWT with sham therapy.35–37,39,40 Two satisfactory quality studies36,39 and a high quality study37 revealed that ESWT was no more effective than sham therapy in treating tennis elbow. On the other hand, positive effects of ESWT in the management of tennis elbow showed a satisfactory quality study35 and a high quality study.40 Moreover, a satisfactory quality study, comparing steroid injection with ESWT, found the injection was more effective than the ESWT in the management of tennis elbow.38 Finally a satisfactory quality study comparing two techniques of ESWT (lateral and back) in the management of tennis elbow found no differences between them, but improvement in relation to the baseline.41


In this review, the effectiveness of ESWT was assessed by searching databases in combination with reference checking for randomised controlled clinical trials. It is the first to include a satisfactory number of studies that assessed the effectiveness of ESWT in the management of tennis elbow. Conflicting results were found.

ESWT is a relatively new treatment recently introduced for managing common tendon problems such as tennis elbow with the aim to produce analgesia, although the mechanism of analgesia remains the same. It has been used for years as the standard treatment for disintegrating kidney stones.33 Although we found conflicting results on its effectiveness in the management of tennis elbow, it cannot be ruled out from research, as it is a dose-response modality and the optimal treatment dose has obviously not yet been discovered. It was our intention to carry this out as a dose-response analysis. However, it was difficult to test for a dose response, because of poor reporting of variables and a dearth of clinical studies comparing the effectiveness of different treatment modality variables.42

Two previous systematic reviews, Smidt et al43 and Trudel et al,44 evaluated the effectiveness of physiotherapy and conservative treatments in the management of tennis elbow respectively without examining the effects of ESWT. Neither review explained why this occurred. Moreover, a systematic review of no dose response parameters was carried out in both, as we did in our review.

Although overall the quality of studies included in the review was satisfactory, there were methodological limitations. Many of the studies failed to provide adequate long term follow up, blinding, and power calculations. The use of standardised outcome measures was another area of particular deficit. Finally, the protocol of the intervention was not described in full detail, making replication difficult. Therefore well designed RCTs are needed to investigate the effectiveness of ESWT in the management of tennis elbow.

Methodological limitations of this systematic review include searching in English alone, lack of trials selection blinding, and absence of meta-analyses. However, information on the selection criteria is often missing from the methods section of an article, so blinding has to be broken to retrieve it, as there is evidence that a difference may exist between blinded and unblinded reviews. This is very time consuming, and the differences show little consistency in direction of bias or its magnitude.45 For these reasons, we decided that the reviewer should not to be blinded to the above characteristics, even though this may have increased the possibility of methodological quality and data analysis bias. Moreover, it may sometimes be difficult for reviewers to decide whether it is clinically relevant to combine the results of a group of studies in a meta-analysis—for example, studies of patients with different types of treatment, different types of comparison groups, or different clinical characteristics of patients studied. There is consensus among the editorial board of the Cochrane Back Review Group that, if relevant valid data are lacking (data are too sparse or of too low quality) or if data are statistically and clinically too heterogeneous, a meta-analysis should be avoided and reviewers should perform a qualitative review.46 For these reasons, a qualitative review was conducted.

What is already known on this topic

ESWT is a recommended treatment for tennis elbow.

Finally, we conclude that research with well designed RCTs is required to provide meaningful evidence on the effectiveness of ESWT for the management of tennis elbow.

What this study adds

The results of this review reveal conflicting findings about the effectiveness of ESWT in the management of tennis elbow. Further research with well designed RCTs is needed to establish its absolute and relative effectiveness.


View Abstract


  • Competing interests: none declared

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.